| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |